Mustang Bio, Inc.
Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.39
- 52-Week Range
- $0.35 – $1.43
- Market Cap
- $2.88M
- P/E (TTM)
- —
- EPS (TTM)
- -0.51
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.44
- PEG Ratio
- —
- Return on Equity
- -43.15%
- Return on Assets
- -14.52%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 1.85
- Debt/Equity
- —
- Total Debt
- $0.00
- Free Cash Flow
- $-3.93M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $-11.39M
Market Snapshot
About
Mustang Bio is a clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases.